In an attempt to be more competitive and efficient in this environment, today's sites are implementing tighter financial management, overseeing regulatory compliance more intensively, striving to achieve status as a preferred partner, and adopting clinical trials management systems (CTMS) to streamline operations and replace paper-based processes.
"When it comes to CTMS, current solutions in the marketplace leave a lot to be desired," said Kalluri.
With what is currently available, sites have to choose between products with bloated functionality and complex interfaces that require up-front investments in infrastructure, have ongoing maintenance and administrative overhead, and have long training cycles with slow user adoption rates.
By contrast, the Allegro product line is built for clinical research operations excellence with no software to install and no systems administration required, real-time visibility into the entire clinical research portfolio, and a user-centric, intuitive interface that is easy to use, virtually eliminating the need for training. With Allegro CTMS@Site, sites can get up and running in a single day.
Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers.
PercipEnz Technologies is now Forte Research Systems. Same company, new name.
|SOURCE Forte Research Systems|
Copyright©2010 PR Newswire.
All rights reserved